Evidence map›Paper›PMID 32951301›Full record

Trial reportJournal of clinical hypertension (Greenwich, Conn.)2020

Effect of vitamin D supplementation versus placebo on essential hypertension in patients with vitamin D deficiency: a double-blind randomized clinical trial.

Vida Sheikh, Azadeh Mozaianimonfared, Mohsen Gharakhani, Jalal Poorolajal, Ph D

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Effect of vitamin BBMJ open · 2024
    Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Vitamin D and hypertension in the elderly; closer to implementation!American heart journal plus : cardiology research and practice · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Vitamin D and hypertension: Is there any significant relation?Chronic diseases and translational medicine · 2024
    Article
  14. Article
  15. Review
  16. Review
  17. Latest Knowledge on the Role of Vitamin D in Hypertension.International journal of molecular sciences · 2023
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vida SheikhDepartment of Internal Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Azadeh MozaianimonfaredDepartment of Cardiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Mohsen GharakhaniDepartment of Cardiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Ph DDepartment of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
Hamedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Findings from randomized trials addressing the effect of vitamin D supplementation and blood pressure are inconsistent and have been the subject of recent debate. This study aimed to assess the effect of vitamin D supplementation on primary hypertension. This double-blind randomized clinical trial was conducted on patients aged 26-84 years with essential hypertension from March 2017 to April 2019. Patients with vitamin D insufficiency (serum vitamin D levels 20-30 ng/ml) or vitamin D deficiency (serum vitamin D levels <20 ng/ml) were enrolled in the study. Patients were randomly assigned to receive vitamin D supplementation or placebo. Systolic and diastolic blood pressure was measured before the intervention and one and two months thereafter. Of 208 patients enrolled, 171 patients remained for analysis. The effect of vitamin D supplementation on systolic blood pressure was statistically significant in the first and second months after the intervention (P=0.004 and P=0.024, respectively). The effect of vitamin D supplementation on diastolic blood pressure was statistically significant in the first month after the intervention (P=0.046), but not in the second month (P=0.885). No evidence of drug side effects was reported in the two groups. The results of this trial are suggestive of the potential benefits of vitamin D supplementation on blood pressure end points. Therefore, the use of vitamin D may be recommended as an adjuvant drug in the treatment of essential hypertension in patients with vitamin D deficiency because it is safe and well-tolerated by the patients and can significantly reduce the systolic and diastolic blood pressure. Trial registration: Iranian Registry of Clinical Trials registration number: IRCT201703129014N151.

Indexed as

Vitamin D DeficiencyAdultAgedAged, 80 and overBlood PressureDietary SupplementsDouble-Blind MethodEssential HypertensionHumansIranMiddle AgedVitamin DVitamin DBlood PressureClinical TrialHypertensionVitamin D Deficiency

Identifiers

PMID32951301
PMCPMC8030057
OpenAlexW3087439516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.